Loading…

Right ventricular systolic function in hypertensive heart failure

Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor...

Full description

Saved in:
Bibliographic Details
Published in:Vascular health and risk management 2017-01, Vol.13, p.353-360
Main Authors: Oketona, O A, Balogun, M O, Akintomide, A O, Ajayi, O E, Adebayo, R A, Mene-Afejuku, T O, Oketona, O T, Bamikole, O J
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423
cites
container_end_page 360
container_issue
container_start_page 353
container_title Vascular health and risk management
container_volume 13
creator Oketona, O A
Balogun, M O
Akintomide, A O
Ajayi, O E
Adebayo, R A
Mene-Afejuku, T O
Oketona, O T
Bamikole, O J
description Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters. One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S'). RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF. A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.
doi_str_mv 10.2147/VHRM.S142429
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A535420919</galeid><doaj_id>oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1</doaj_id><sourcerecordid>A535420919</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</originalsourceid><addsrcrecordid>eNptktuLEzEUxgdR3HX1zWcZEMQHW3OdTF6Esqi7sCKsl9eQyZy0KWlSk5lC_3szti6tSB4STn75ci5fVb3EaE4wE-9_3tx_mX_DjDAiH1WXGIt2RhBrH5-cL6pnOa8R4k2L8NPqgkhEKRftZbW4d8vVUO8gDMmZ0etU530eonemtmMwg4uhdqFe7beQBgjZ7aBegU5DbbXzY4Ln1ROrfYYXx_2q-vHp4_frm9nd18-314u7meGiGWaYW6Fb29EGN1wyS3VDwPZIEGF62UmmeSdQp0tqPcgeDO046YTEHIGWjNCr6vag20e9VtvkNjrtVdRO_QnEtFQlK2c8KMYb02sjeuAd65hokZWEUmo1xiA0LlofDlrbsdtAb6bqtT8TPb8JbqWWcad4Q1qBUBF4exRI8dcIeVAblw14rwPEMSssOeYNJVIU9PU_6DqOKZRWKUIKgIUUJ9RSlwJcsLH8ayZRteCUM4IkloWa_4cqq4eNMzGAdSV-9uDNyYMyNz-scvTjNNZ8Dr47gCbFnBPYh2ZgpCafqcln6uizgr86beAD_NdY9DcaQ8wn</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229717977</pqid></control><display><type>article</type><title>Right ventricular systolic function in hypertensive heart failure</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</creator><creatorcontrib>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</creatorcontrib><description>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters. One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S'). RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF. A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</description><identifier>ISSN: 1178-2048</identifier><identifier>ISSN: 1176-6344</identifier><identifier>EISSN: 1178-2048</identifier><identifier>DOI: 10.2147/VHRM.S142429</identifier><identifier>PMID: 29033578</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Aged ; Beta blockers ; Blood pressure ; Cardiovascular disease ; Care and treatment ; Case-Control Studies ; Complications and side effects ; Cross-Sectional Studies ; Development and progression ; Echocardiography ; Echocardiography, Doppler ; Electrocardiography ; Female ; Health care ; Heart failure ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Heart Failure - physiopathology ; Humans ; Hypertension ; Hypertension - diagnostic imaging ; Hypertension - epidemiology ; Hypertension - physiopathology ; Male ; Medical examination ; Medical prognosis ; Medicine ; Methods ; Middle Aged ; Morphology ; Nigeria - epidemiology ; Original Research ; Prevalence ; Prognosis ; Right heart ventricle ; Right ventricle ; RV MPI ; RV S ; Stroke Volume ; Systole ; systolic function ; TAPSE ; Teaching hospitals ; Ultrasonic imaging ; Ventricular Dysfunction, Right - diagnosis ; Ventricular Dysfunction, Right - epidemiology ; Ventricular Dysfunction, Right - physiopathology ; Ventricular Function, Left ; Ventricular Function, Right</subject><ispartof>Vascular health and risk management, 2017-01, Vol.13, p.353-360</ispartof><rights>COPYRIGHT 2017 Dove Medical Press Limited</rights><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Oketona et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</citedby><orcidid>0000-0001-9107-8476 ; 0000-0001-5205-9344 ; 0000-0003-4993-0789</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2229717977/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2229717977?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29033578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oketona, O A</creatorcontrib><creatorcontrib>Balogun, M O</creatorcontrib><creatorcontrib>Akintomide, A O</creatorcontrib><creatorcontrib>Ajayi, O E</creatorcontrib><creatorcontrib>Adebayo, R A</creatorcontrib><creatorcontrib>Mene-Afejuku, T O</creatorcontrib><creatorcontrib>Oketona, O T</creatorcontrib><creatorcontrib>Bamikole, O J</creatorcontrib><title>Right ventricular systolic function in hypertensive heart failure</title><title>Vascular health and risk management</title><addtitle>Vasc Health Risk Manag</addtitle><description>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters. One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S'). RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF. A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</description><subject>Aged</subject><subject>Beta blockers</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Complications and side effects</subject><subject>Cross-Sectional Studies</subject><subject>Development and progression</subject><subject>Echocardiography</subject><subject>Echocardiography, Doppler</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Health care</subject><subject>Heart failure</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnostic imaging</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical examination</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Morphology</subject><subject>Nigeria - epidemiology</subject><subject>Original Research</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Right heart ventricle</subject><subject>Right ventricle</subject><subject>RV MPI</subject><subject>RV S</subject><subject>Stroke Volume</subject><subject>Systole</subject><subject>systolic function</subject><subject>TAPSE</subject><subject>Teaching hospitals</subject><subject>Ultrasonic imaging</subject><subject>Ventricular Dysfunction, Right - diagnosis</subject><subject>Ventricular Dysfunction, Right - epidemiology</subject><subject>Ventricular Dysfunction, Right - physiopathology</subject><subject>Ventricular Function, Left</subject><subject>Ventricular Function, Right</subject><issn>1178-2048</issn><issn>1176-6344</issn><issn>1178-2048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptktuLEzEUxgdR3HX1zWcZEMQHW3OdTF6Esqi7sCKsl9eQyZy0KWlSk5lC_3szti6tSB4STn75ci5fVb3EaE4wE-9_3tx_mX_DjDAiH1WXGIt2RhBrH5-cL6pnOa8R4k2L8NPqgkhEKRftZbW4d8vVUO8gDMmZ0etU530eonemtmMwg4uhdqFe7beQBgjZ7aBegU5DbbXzY4Ln1ROrfYYXx_2q-vHp4_frm9nd18-314u7meGiGWaYW6Fb29EGN1wyS3VDwPZIEGF62UmmeSdQp0tqPcgeDO046YTEHIGWjNCr6vag20e9VtvkNjrtVdRO_QnEtFQlK2c8KMYb02sjeuAd65hokZWEUmo1xiA0LlofDlrbsdtAb6bqtT8TPb8JbqWWcad4Q1qBUBF4exRI8dcIeVAblw14rwPEMSssOeYNJVIU9PU_6DqOKZRWKUIKgIUUJ9RSlwJcsLH8ayZRteCUM4IkloWa_4cqq4eNMzGAdSV-9uDNyYMyNz-scvTjNNZ8Dr47gCbFnBPYh2ZgpCafqcln6uizgr86beAD_NdY9DcaQ8wn</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Oketona, O A</creator><creator>Balogun, M O</creator><creator>Akintomide, A O</creator><creator>Ajayi, O E</creator><creator>Adebayo, R A</creator><creator>Mene-Afejuku, T O</creator><creator>Oketona, O T</creator><creator>Bamikole, O J</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9107-8476</orcidid><orcidid>https://orcid.org/0000-0001-5205-9344</orcidid><orcidid>https://orcid.org/0000-0003-4993-0789</orcidid></search><sort><creationdate>20170101</creationdate><title>Right ventricular systolic function in hypertensive heart failure</title><author>Oketona, O A ; Balogun, M O ; Akintomide, A O ; Ajayi, O E ; Adebayo, R A ; Mene-Afejuku, T O ; Oketona, O T ; Bamikole, O J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Beta blockers</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Complications and side effects</topic><topic>Cross-Sectional Studies</topic><topic>Development and progression</topic><topic>Echocardiography</topic><topic>Echocardiography, Doppler</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Health care</topic><topic>Heart failure</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnostic imaging</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical examination</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Morphology</topic><topic>Nigeria - epidemiology</topic><topic>Original Research</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Right heart ventricle</topic><topic>Right ventricle</topic><topic>RV MPI</topic><topic>RV S</topic><topic>Stroke Volume</topic><topic>Systole</topic><topic>systolic function</topic><topic>TAPSE</topic><topic>Teaching hospitals</topic><topic>Ultrasonic imaging</topic><topic>Ventricular Dysfunction, Right - diagnosis</topic><topic>Ventricular Dysfunction, Right - epidemiology</topic><topic>Ventricular Dysfunction, Right - physiopathology</topic><topic>Ventricular Function, Left</topic><topic>Ventricular Function, Right</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oketona, O A</creatorcontrib><creatorcontrib>Balogun, M O</creatorcontrib><creatorcontrib>Akintomide, A O</creatorcontrib><creatorcontrib>Ajayi, O E</creatorcontrib><creatorcontrib>Adebayo, R A</creatorcontrib><creatorcontrib>Mene-Afejuku, T O</creatorcontrib><creatorcontrib>Oketona, O T</creatorcontrib><creatorcontrib>Bamikole, O J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vascular health and risk management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oketona, O A</au><au>Balogun, M O</au><au>Akintomide, A O</au><au>Ajayi, O E</au><au>Adebayo, R A</au><au>Mene-Afejuku, T O</au><au>Oketona, O T</au><au>Bamikole, O J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Right ventricular systolic function in hypertensive heart failure</atitle><jtitle>Vascular health and risk management</jtitle><addtitle>Vasc Health Risk Manag</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>13</volume><spage>353</spage><epage>360</epage><pages>353-360</pages><issn>1178-2048</issn><issn>1176-6344</issn><eissn>1178-2048</eissn><abstract>Heart failure (HF) is a major cause of cardiovascular admissions and hypertensive heart failure (HHF) is the most common cause of HF admissions in sub-Saharan Africa, Nigeria inclusive. Right ventricular (RV) dysfunction is being increasingly recognized in HF and found to be an independent predictor of adverse outcomes in HF. This study aimed to determine the prevalence of RV systolic dysfunction in HHF by several echocardiographic parameters. One hundred subjects with HHF were recruited consecutively into the study along with 50 age and sex-matched controls. All study participants gave written informed consent, and had a full physical examination, blood investigations, 12-lead electrocardiogram, and transthoracic echocardiography. RV systolic function was assessed in all subjects using different methods based on the American Society of Echocardiography guidelines for echocardiographic assessment of the right heart in adults. This included tricuspid annular plane systolic excursion (TAPSE), RV myocardial performance index (MPI), and RV systolic excursion velocity by tissue Doppler (S'). RV systolic dysfunction was found in 53% of subjects with HHF by TAPSE, 56% by RV MPI, and 48% by tissue Doppler systolic excursion S'. RV systolic dysfunction increased with reducing left ventricular ejection fraction (LVEF) in subjects with HHF. A high proportion of subjects with HHF were found to have RV systolic functional abnormalities using TAPSE, RV MPI, and RV S'. Prevalence of RV systolic dysfunction increased with reducing LVEF.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>29033578</pmid><doi>10.2147/VHRM.S142429</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9107-8476</orcidid><orcidid>https://orcid.org/0000-0001-5205-9344</orcidid><orcidid>https://orcid.org/0000-0003-4993-0789</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-2048
ispartof Vascular health and risk management, 2017-01, Vol.13, p.353-360
issn 1178-2048
1176-6344
1178-2048
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_456cdac7de5b4b4780f92333fa11e7a1
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central(OpenAccess)
subjects Aged
Beta blockers
Blood pressure
Cardiovascular disease
Care and treatment
Case-Control Studies
Complications and side effects
Cross-Sectional Studies
Development and progression
Echocardiography
Echocardiography, Doppler
Electrocardiography
Female
Health care
Heart failure
Heart Failure - diagnosis
Heart Failure - epidemiology
Heart Failure - physiopathology
Humans
Hypertension
Hypertension - diagnostic imaging
Hypertension - epidemiology
Hypertension - physiopathology
Male
Medical examination
Medical prognosis
Medicine
Methods
Middle Aged
Morphology
Nigeria - epidemiology
Original Research
Prevalence
Prognosis
Right heart ventricle
Right ventricle
RV MPI
RV S
Stroke Volume
Systole
systolic function
TAPSE
Teaching hospitals
Ultrasonic imaging
Ventricular Dysfunction, Right - diagnosis
Ventricular Dysfunction, Right - epidemiology
Ventricular Dysfunction, Right - physiopathology
Ventricular Function, Left
Ventricular Function, Right
title Right ventricular systolic function in hypertensive heart failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A46%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Right%20ventricular%20systolic%20function%20in%20hypertensive%20heart%20failure&rft.jtitle=Vascular%20health%20and%20risk%20management&rft.au=Oketona,%20O%20A&rft.date=2017-01-01&rft.volume=13&rft.spage=353&rft.epage=360&rft.pages=353-360&rft.issn=1178-2048&rft.eissn=1178-2048&rft_id=info:doi/10.2147/VHRM.S142429&rft_dat=%3Cgale_doaj_%3EA535420919%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-15f7a8fb3616594f3a62efd0727cd9b94a5b70ba290de9dec3b52b79150ea9423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229717977&rft_id=info:pmid/29033578&rft_galeid=A535420919&rfr_iscdi=true